Agilent Integrates Cell Analysis Division into Diagnostics and Genomics Group for Strategic Growth

Agilent Technologies announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy ...

December 21, 2023 | Thursday | News
Wolters Kluwer leaders predict accelerated AI transformation for healthcare in 2024

As 2024 nears, the healthcare landscape is undergoing unprecedented transformations, particularly with headlines about artificial intelligence (AI) technol...

December 21, 2023 | Thursday | News
TriMas Life Sciences Expands Its Cleanroom Capabilities

TriMas (NASDAQ: TRS)  announced that its Intertech business, part of the TriMas Life Sciences division, has expanded its cleanroom capacity at its Den...

December 19, 2023 | Tuesday | News
BioNTech Hits Milestone with mRNA Vaccine Facility in Rwanda

Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a resilient vaccine ecosystem in Afr...

December 19, 2023 | Tuesday | News
Parse Biosciences Secures $50M for Global Growth

Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...

December 18, 2023 | Monday | News
OmniAb Unveils Latest Scientific Data on OmnidAb™ Platform at 2023 Antibody Engineering Conference

OmniAb, Inc.  announces the presentation of new scientific data on its OmnidAb™ platform, the industry’s first and only transgenic chicken...

December 15, 2023 | Friday | News
Novozymes and Chr. Hansen Unveil Unified Identity: Novonesis, Marking a Powerful Synergy in the Biotech Industry

Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis wi...

December 13, 2023 | Wednesday | News
South Korean Genomics Giant, Macrogen, Secures Strong Presence in Basel, Switzerland

  Macrogen Europe is seeking to expand within Switzerland from its foothold in Basel with its Sanger sequencing laborato...

December 13, 2023 | Wednesday | News
Freya Biosciences Raises $38M in Significant Series A for Women’s Reproductive Immunotherapies

Series A led by Sofinnova Partners and OMX Ventures Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announced today a ...

December 12, 2023 | Tuesday | News
SkylineDx and VIB Initiate Joint Research Program on Immune Prediction

The significant milestone marks the first result of the company's strategic partnership2 with VIB, Flanders' leading life sciences institute, and potential...

December 11, 2023 | Monday | News
Merck Partners with Acceleration Consortium for AI-Driven Experimentation Open Source

Bayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership to enable the self-d...

December 11, 2023 | Monday | News
IMIDomics and Bristol Myers Squibb Extend Partnership for Inflammatory Disease Research

In 2016, IMIDomics entered into a strategic partnership with BMS to harness their unique clinical and molecular database, and multidimensional analysis con...

December 07, 2023 | Thursday | News
Sanofi's Pipeline Transformation for Immunology Leadership Through Record Potential Blockbusters

Details strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with ...

December 07, 2023 | Thursday | News
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, O...

December 04, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close